This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Engelhardt, S. Articles by Brodde, O.-E. Search for Related Content PubMed PubMed Citation Articles by Engelhardt, S. Articles by Brodde, O.-E.

Tocolytic Therapy with Fenoterol Induces Selective Down-Regulation of ß-Adrenergic Receptors in Human Myometrium¹

Institut für Pharmakologie und Toxikologie der Universität Würzburg, Würzburg (S.E., M.J.L.); Frauenklinik (W.Z.), Mannheim; Medizinische Klinik und Poliklinik der Universität Essen (J.K., M.C.M., O.-E.B.), Essen; and Institut für Pharmakologie und Toxikologie der Universität Halle (O.-E.B.), Germany

Address all correspondence and requests for reprints to: O.-E. Brodde, Institut für Pharmakologie und Toxikologie, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Strasse 4, D-06097 Halle, Germany.

Tocolytic therapy with ß-adrenergic receptor agonists is a standard regimen to prevent preterm birth. Agonist exposure of ß-adrenergic receptors causes receptor desensitization in other organs, and this may limit the therapeutic value of ß-adrenergic receptor agonists. To study the effects of prolonged ß-adrenergic agonist treatment in human myometrium, we obtained biopsies during Caesarean section of 14 pregnant patients who had received fenoterol for at least 5 days and 14 untreated pregnant controls. The densities of total ß-adrenergic receptors, which are mainly of the ß₂-subtype as assessed by [¹²⁵I]iodo-cyanopindolol binding in crude membrane fractions, were more than 50% smaller in women receiving fenoterol, whereas ₂-adrenergic receptor densities were similar. G_s and G_i G-protein -subunit densities were unaltered as assessed by Western blotting and pertussis toxin-catalyzed [³²P]ADP-ribosylation. ß-Adrenergic receptor kinase (ßARK) activity, as determined using bovine rhodopsin as the substrate, was the same in the two groups. Adenylyl cyclase activities in the presence of guanine nucleotides, NaF, forskolin, or Mn⁺⁺ were also not altered by fenoterol treatment. The messenger RNA (mRNA) concentrations of ß₂-adrenergic receptors, ßARK-I and glyceraldehyde-3-phosphate dehydrogenase (as a reference), as determined by quantitative PCR, were unaffected by fenoterol treatment. We conclude that tocolysis with fenoterol results in a selective down-regulation of myometrial ß-adrenergic receptors, which is not associated with a reduction in the respective mRNA concentrations or alterations of ₂-adrenergic receptors, G_s and G_i -subunits, or ßARK activity or mRNA.

This article has been cited by other articles:

				T. Croci, R. Cecchi, P. Marini, C. Rouget, N. Viviani, G. Germain, F. Guagnini, Y. Fradin, L. Descamps, M. Pascal, et al. In Vitro and in Vivo Pharmacological Characterization of Ethyl-4-{trans-4-[((2S)-2-hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl) Amino]cyclohexyl}benzoate Hydrochloride (SAR150640), a New Potent and Selective Human beta3-Adrenoceptor Agonist for the Treatment of Preterm Labor J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1118 - 1126. [Abstract] [Full Text] [PDF]

				C. Rouget, O. Barthez, F. Goirand, M.J. Leroy, M. Breuiller-Fouche, Z. Rakotoniaina, P. Guerard, E.J. Morcillo, C. Advenier, P. Sagot, et al. Stimulation of the ADRB3 Adrenergic Receptor Induces Relaxation of Human Placental Arteries: Influence of Preeclampsia Biol Reprod, January 1, 2006; 74(1): 209 - 216. [Abstract] [Full Text] [PDF]

				T. Frambach, T. Muller, S. Freund, S. Engelhardt, M. Sutterlin, M. J. Lohse, and J. Dietl Self-Limitation of Intravenous Tocolysis with {beta}2-Adrenergic Agonists Is Mediated through Receptor G Protein Uncoupling J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2882 - 2887. [Abstract] [Full Text] [PDF]

				C. Rouget, M. Bardou, M. Breuiller-Fouche, C. Loustalot, H. Qi, E. Naline, T. Croci, D. Cabrol, C. Advenier, and M. J. Leroy {beta}3-Adrenoceptor Is the Predominant {beta}-Adrenoceptor Subtype in Human Myometrium and Its Expression Is Up-Regulated in Pregnancy J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1644 - 1650. [Abstract] [Full Text] [PDF]

				T. Teli, D. Markovic, M. A. Levine, E. W. Hillhouse, and D. K. Grammatopoulos Regulation of Corticotropin-Releasing Hormone Receptor Type 1{alpha} Signaling: Structural Determinants for G Protein-Coupled Receptor Kinase-Mediated Phosphorylation and Agonist-Mediated Desensitization Mol. Endocrinol., February 1, 2005; 19(2): 474 - 490. [Abstract] [Full Text] [PDF]

				X.-B. Zhou, G.-X. Wang, B. Huneke, T. Wieland, and M. Korth Pregnancy switches adrenergic signal transduction in rat and human uterine myocytes as probed by BKCa channel activity J. Physiol., April 15, 2000; 524(2): 339 - 352. [Abstract] [Full Text] [PDF]

				S. GSELL, T. ESCHENHAGEN, G. KASPAREIT, M. NOSE, H. SCHOLZ, O. BEHRENS, and T. WIELAND Apparent up-regulation of stimulatory G-protein {alpha} subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression, FASEB J, January 1, 2000; 14(1): 17 - 26. [Abstract] [Full Text]

				O.-E. Brodde and M. C. Michel Adrenergic and Muscarinic Receptors in the Human Heart Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690. [Abstract] [Full Text] [PDF]

				J.-L. Lécrivain, J. Cohen-Tannoudji, M.-T. Robin, N. Coudouel, C. Legrand, and J.-P. Maltier Molecular Mechanisms of Adenylyl Cyclase Desensitization in Pregnant Rat Myometrium following In Vivo Administration of the ss-Adrenergic Agonist, Isoproterenol Biol Reprod, July 1, 1998; 59(1): 45 - 52. [Abstract] [Full Text]